|
|
|
|
LEADER |
00825cas a2200265 a 4500 |
001 |
vtls001369066 |
003 |
ISSN |
005 |
20181113111415.0 |
006 |
aa ||||||||||||| |
007 |
ta |
008 |
180108c19979999enkqr|p 0 a0eng |
022 |
0 |
|
|a 1369-0663
|2 _2
|l 1369-0663
|
035 |
|
|
|a (ISSN)13690663
|
040 |
|
|
|c CNCS
|
044 |
|
|
|c GBR
|
082 |
0 |
4 |
|a 338.476151094
|2 21
|
210 |
1 |
|
|a Eur. biopharm. rev.
|
222 |
|
|
|a European biopharmaceutical review
|
245 |
1 |
|
|a European biopharmaceutical review.
|
246 |
1 |
3 |
|a EBR
|
260 |
|
|
|a London :
|b Ballantyne Ross,
|c 1997-
|
362 |
0 |
|
|a Sept. 1997-
|
942 |
|
|
|2 ddc
|c CR
|
999 |
|
|
|c 144990
|d 144990
|
952 |
|
|
|0 0
|1 0
|4 0
|7 0
|9 1734078
|a CO-CBUA-UCO-MH
|b CO-CBUA-UCO-MH
|h (1997-2001),(2003-09),(2013),(2016).
|o CO-CBUA-UCO-MH-1734078JNL-1369-0663
|p CO-CBUA-UCO-MH-1734078JNL-144990
|t 2441949
|y JNL
|